Disease of aging
Hypertension
Last updated 2026-05-30· 1 min read· Evidence: rct
Reviewed by the Ultimate Longevity Bible editorial team. Educational reference — not medical advice. See disclaimer.
Why aggressive treatment pays
SPRINT and STEP showed lowering systolic BP to <120 (intensively measured) reduces cardiovascular events and all-cause mortality in high-risk older adults. Even modest 5 mmHg systolic reductions produce roughly 10% relative reductions in major events.
Lifestyle foundation
- DASH or Mediterranean-style diet (-5 to -10 mmHg).
- Weight loss (~1 mmHg per kg lost in obese).
- Sodium reduction (-2 to -8 mmHg if salt-sensitive).
- Aerobic exercise (-4 mmHg) + resistance training.
- Alcohol moderation.
- Stress management.
Drug classes
| Class | Examples | Notes |
|---|---|---|
| ACE inhibitors | lisinopril, ramipril, perindopril | First-line; cough side-effect |
| ARBs | losartan, telmisartan, valsartan | First-line; no cough |
| Calcium-channel blockers | amlodipine, nifedipine | Effective; ankle oedema |
| Thiazide-like | chlorthalidone, indapamide | More potent than HCTZ |
| Mineralocorticoid antagonists | spironolactone, eplerenone | For resistant HTN |
| Beta-blockers | bisoprolol, metoprolol | Less first-line unless concurrent CAD/HF |
Single-pill combination therapy improves adherence and is now preferred initial strategy in moderate-severe hypertension.
Resistant hypertension
BP not controlled on three drugs including a diuretic at maximum tolerated doses. Workup: secondary causes (primary aldosteronism, renovascular, OSA), adherence assessment, ambulatory monitoring, optimise diuretic. Add spironolactone.
- Stroke — Disease.
- Sodium — The Controversy — Nutrition entry.
- Home Blood-Pressure Cuff — Tool.
Related entries
References
- SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103–2116 (2015).